To study the role that epithelial cells of the thymic microenvironment play in promoting activation of immature CD7+, CD2+, CD4-, CD8-(double-negative) human thymocytes, we have isolated thymocyte subsets from normal postnatal thymus and have cocultured autologous double-negative thymocytes with pure populations of thymic epithelial (TE) cells. We report that TE cells directly activate double-negative thymocytes to proliferate and that TE cells enhance the ability of double-negative thymocytes to proliferate in response to stimulation with exogenous interleukin 2. Activated double-negative thymocytes that proliferated in vitro in the presence of TE cells and interleukin 2 remained doublenegative after 23 days in culture. Moreover, TE-cell culture supernatants in the absence of intact TE cells contain interleukin 1, interleukin 3, and granulocyte/macrophage-colonystimulating factor activity for human bone marrow cells and can activate double-negative thymocytes to proliferate. Antibodies against interleukin 1 and against granulocyte/macrophage-colony-stimulating factor inhibited TE-cell-induced thymocyte activation. These data indicate that one role of TE cells in vivo may be to activate double-negative thymocytes to proliferate.
development, intrathymic T cells are CD7+, CD2+, CD4-, CD8-(double-negative) (14) (15) (16) .
To study the role that thymic epithelial (TE) cells might play in activating subsets of human double-negative thymocytes to proliferate and differentiate into mature T cells, we developed an in vitro coculture system of autologous TE cells and double-negative thymocytes (17) . Here we show that TE cells up-regulate interleukin 2 (IL-2) receptor expression and IL-2 responsiveness of double-negative thymocytes and directly activate immature thymocytes to proliferate.
Moreover, TE cells produce cytokines capable of providing activation signals to double-negative thymocytes in the absence of direct TE-cell-thymocyte contact.
MATERIALS AND METHODS Antibodies. Antibodies 3A1 (CD7) (18) , TS29.1 (anti-LFA-3) (19, 20) , and TS122 (CD18) (19, 20) were used as previously described. Monoclonal antibodies 35 .1 and 9.6 (21) were the gift of John Hansen. Monoclonal antibodies T3/RW2-4B6 (CD3), T4/19Thy5D7 (CD4), and T8/21Thy2D3 (CD8) were the gift of Ellis Reinherz (Dana-Farber Cancer Institute, Boston, MA). Antibodies Leu-M3 (22) , WT31 (23) , and anti-Tac (24) were gifts of Robert Winchester, Wil Tax, and Thomas Waldmann, respectively. Antibodies L243 (25) and 3F10 (26) , which bind to nonpolymorphic determinants of major histocompatibility complex (MHC) class II and class I molecules, respectively, were obtained from the American Type Culture Collection. Rabbit polyclonal antibody against interleukin 1 (IL-1) (27) was the gift of Charles Dinarello. Rabbit antibodies against interleukin and against granulocyte/macrophage-colony-stimulating factor (GM-CSF) were gifts of Steven Clark (Genetics Institute, Cambridge, MA).
Cell Preparation. Thymic tissue was obtained from normal children (aged 1 day to 8 years) undergoing median sternotomy incision and corrective cardiovascular surgery. TE-cell cultures were established by an explant technique and were subcultured as described (28) . Thymocytes were separated and purified as described (17) . Double-negative (CD4-, CD8-) thymocytes were prepared by "panning" (29, 30) and preparative cell sorting.
Proliferation Assays. Thymocyte proliferation was assayed by measurement of [3H]thymidine incorporation as described (17) . Recombinant IL-2, kindly provided by Cetus Corporation (Emeryville, CA), was used at final concentrations of 0.5-10 units/ml. Recombinant human GM-CSF, a gift of Steven Clark, was used at final concentrations of units/ml. In some experiments, anti-Tac, anti-IL-2 (Collaborative Research, Boston, MA), anti-IL-1, anti-IL-3, and anti-GM-CSF antibodies were added to cocultures ofTE cells and double-negative thymocytes at saturating amounts (1:500 dilution of ascites, purified antibody at 50 ,ug/ml, 1:100 dilution of rabbit polyclonal antibody, 1:100 dilution of rabbit polyclonal antibody, and 1:500 dilution of rabbit polyclonal antibody, respectively). (17) . As specificity controls, neither human erythrocytes, human epidermal cells, nor the human epithelial carcinoma cell line A-431 induced activation of double-negative thymocytes (data not shown).
To determine the number of double-negative thymocytes responding to TE-cell activation signals in 5-day cocultures, we counted blasts and mitotic figures in Wright-stained cytocentrifuge preparations (17) . In three separate experiments, whereas double-negative thymocyte suspensions cultured alone for 5 Response of Immature Thymocytes to TE Cells and IL-2. As shown in Table 1 , addition of as little as 0.5 unit of recombinant IL-2 per ml of culture medium induced doublenegative thymocytes to proliferate. Furthermore, addition of 10% TE cells substantially enhanced the proliferative response of double-negative thymocytes to IL-2 (P < 0.005).
In indirect immunofluorescence assays of 20 different samples, 11 ± 3% of double-negative thymocytes prior to in vitro culture expressed 55-kDa (p55) IL-2 receptor subunits as determined by reactivity with anti-Tac antibody. After (Fig. 2) demonstrated that 92% ofthe cells were CD4-, CD8 -(double-negative) with varying proportions expressing CD2 (60%) and CD3 (27%). Importantly, double-negative thymocytes at day 23 were nonreactive with antibodies against Ti a and chains (WT31) and the CD1 (T6) antigen (Fig. 2) . Myeloid marker expression on these cells was minimal, with 6% of the cells Mo-i .
In contrast to day 5, when 32 8% of double-negative thymocytes expressed IL-2 receptors (as measured by antiTac), by day 23 only 2% were Tac+ (Fig. 2) .
TE-Cell Culture Supernatant Contains GM-CSF and IL-3 Activity and Can Activate Double-Negative Thymocytes. TEcell-thymocyte binding is inhibited by anti-CD2 and anti-LFA-3 antibodies (37). To investigate whether TE-cell activation of double-negative thymocytes could be similarly inhibited, we assayed the effect of a panel of monoclonal antibodies on TE-cell/double-negative thymocyte cocultures. Neither antibodies to MHC class I or class II antigens nor antibodies to CD2, LFA-3, or CD7 antigens significantly inhibited double-negative thymocyte activation as measured by [3H]thymidine incorporation (P > 0.5; data not shown). Since anti-CD2 and anti-LFA-3 antibodies blocked binding of TE cells to thymocytes but did not block TE-cell-induced activation of double-negative thymocytes, we reasoned that direct cell contact could not be solely responsible for the activation. Thus, we tested whether TE-cell supernatant contained cytokine activities other than IL-1 (38) and whether this supernatant could activate double-negative thymocytes in the absence of intact TE cells. As shown in Table 3 , TE-cell supernatant indeed contained both GM-CSF-and IL-3-like activity as determined by its effect on bone marrow mononuclear cells. In addition, in three separate experiments, both TE-cell supernatant [at a concentration of 1:5 (vol/vol) in culture] and IL-3 were capable of activating double-negative thymocytes to proliferate (Table  4) . When recombinant GM-CSF was added to cultures of double-negative thymocytes, proliferative responses were observed with GM-CSF concentrations as low as 4 units/ml, with peak responses at 16 units/ml (Table 4) . Inhibition of TE-Cell Activation of Double-Negative Thymocytes. To investigate the mechanisms of TE-cell-induced thymocyte proliferation, anti-Tac (anti-p55 IL-2 receptor), anti-IL-2, anti-IL-i, anti-IL-3, and anti-GM-CSF antibodies were added singly or in combination to 5-day cocultures of TE cells and double-negative thymocytes. Neither anti-Tac, anti-IL-2, nor anti-IL-3 antibodies inhibited the activation of double-negative thymocytes by TE cells (data not shown). However, antibodies to IL-and to GM-CSF each partially inhibited the activation. Moreover, anti-IL-i and anti-GM-CSF antibodies together inhibited the activation by 70%' (Fig.  3) .
DISCUSSION
In this study, we have shown that human TE cells can activate autologous immature CD4-, CD8-(double-negative) thymocytes and augment immature thymocyte responses to IL-2. TE-cell-induced activation of doublenegative thymocytes led to expansion of both the CD3 + and the CD3 -subpopulations of double-negative thymocytes.
A major consequence of TE cell/double-negative thymocyte coculture was an increase in surface expression of p55 IL-2 receptors on the double-negative thymocytes. This increase was accompanied by an enhancement of the proliferative response of these thymocytes to IL-2. Howe et al. (43) have shown that IL-1 enhances the IL-2-dependent mitogen response of murine double-negative (Lyt2-, L3-8- T4-) thymocytes and increases thymocyte production of IL-2 in response to phorbol 12-myristate 13-acetate and the calcium ionophore ionomycin. Additionally, murine doublenegative thymocytes express receptors for IL-1 and rapidly internalize bound IL-1, suggesting that the receptors are functional. Ceredig (44) reported that phorbol myristate acetate and ionomycin stimulation can similarly increase the response of murine double-negative thymocytes to IL-2 and cause proliferation without differentiation of these doublenegative cells. The observations that human TE cells constitutively produce an IL-1-like activity (38) (46) (47) (48) .
A surprising observation in this study was that anti-CD2 and anti-LFA-3 antibodies that block TE-cell-thymocyte binding (37) did not inhibit TE-cell-induced activation of double-negative thymocytes. Rather, TE-cell supernatant activated double-negative thymocytes in the absence of intact TE cells, and the combination of anti-IL-1 and anti-GM-CSF antibodies inhibited TE-cell-induced thymocyte activation (Fig. 3) . Production of cytokines including macrophage-colony-stimulating factor (CSF-1) has also been found in cloned human TE cells transformed by simian virus 40 (49) . A potential role for GM-CSF or similar cytokines in early T-cell proliferation is suggested by the recent establishment of a human T-cell leukemia line that was GM-CSFdependent and did not proliferate in response to IL-2 (50) . At present, we cannot rule out that TE cells may induce a subset of double-negative thymocytes to produce GM-CSF, leading to thymocyte proliferation in this system.
We have shown that TE cells produce cytokines with GM-CSF-and IL-3-like activities (Table 3) in addition to IL-1 (38 (51) . In the presence of intact TE cells (with binding to thymocytes via CD2 molecules), double-negative thymocytes proliferate, remain lymphoid, and stay double-negative (CD4 -, CD8 -) (Fig. 2) . Moreover, in the absence of intact TE cells, TE-cell supernatant induces subsets of normal double-negative thymocytes to differentiate along myeloid lineage pathways (J.K., P.T.L., S.M.D., and B.F.H., unpublished data). Therefore, TE cells may function in vivo by providing multiple activation signals to immature thymocytes and, by as-yet-uncharacterized mechanisms, participate in lineage determination of T-cell precursors at the time of their arrival in the thymus.
